Literature DB >> 31885094

DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet.

Meiyu Li1,2, Hailiang Tang3, Michael D Chan4, Xiaobo Zhou5, Xiaohua Qian2,4.   

Abstract

PURPOSE: Pseudoprogression (PsP) occurs in 20-30% of patients with glioblastoma multiforme (GBM) after receiving the standard treatment. PsP exhibits similarities in shape and intensity to the true tumor progression (TTP) of GBM on the follow-up magnetic resonance imaging (MRI). These similarities pose challenges to the differentiation of these types of progression and hence the selection of the appropriate clinical treatment strategy.
METHODS: To address this challenge, we introduced a novel feature learning method based on deep convolutional generative adversarial network (DCGAN) and AlexNet, termed DC-AL GAN, to discriminate between PsP and TTP in MRI images. Due to the adversarial relationship between the generator and the discriminator of DCGAN, high-level discriminative features of PsP and TTP can be derived for the discriminator with AlexNet. We also constructed a multifeature selection module to concatenate features from different layers, contributing to more powerful features used for effectively discriminating between PsP and TTP. Finally, these discriminative features from the discriminator are used for classification by a support vector machine (SVM). Tenfold cross-validation (CV) and the area under the receiver operating characteristic (AUC) were applied to evaluate the performance of this developed algorithm.
RESULTS: The accuracy and AUC of DC-AL GAN for discriminating PsP and TTP after tenfold CV were 0.920 and 0.947. We also assessed the effects of different indicators (such as sensitivity and specificity) for features extracted from different layers to obtain a model with the best classification performance.
CONCLUSIONS: The proposed model DC-AL GAN is capable of learning discriminative representations from GBM datasets, and it achieves desirable PsP and TTP classification performance superior to other state-of-the-art methods. Therefore, the developed model would be useful in the diagnosis of PsP and TTP for GBM.
© 2019 American Association of Physicists in Medicine.

Entities:  

Keywords:  deep convolutional generative adversarial network; glioblastoma multiforme; multifeature selection module; pseudoprogression; unsupervised representation learning

Year:  2020        PMID: 31885094     DOI: 10.1002/mp.14003

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

Review 1.  Radiomics in immuno-oncology.

Authors:  Z Bodalal; I Wamelink; S Trebeschi; R G H Beets-Tan
Journal:  Immunooncol Technol       Date:  2021-04-16

Review 2.  Generative Adversarial Networks and Its Applications in Biomedical Informatics.

Authors:  Lan Lan; Lei You; Zeyang Zhang; Zhiwei Fan; Weiling Zhao; Nianyin Zeng; Yidong Chen; Xiaobo Zhou
Journal:  Front Public Health       Date:  2020-05-12

3.  Imaging Biomarkers of Glioblastoma Treatment Response: A Systematic Review and Meta-Analysis of Recent Machine Learning Studies.

Authors:  Thomas C Booth; Mariusz Grzeda; Alysha Chelliah; Andrei Roman; Ayisha Al Busaidi; Carmen Dragos; Haris Shuaib; Aysha Luis; Ayesha Mirchandani; Burcu Alparslan; Nina Mansoor; Jose Lavrador; Francesco Vergani; Keyoumars Ashkan; Marc Modat; Sebastien Ourselin
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

Review 4.  Applications of Artificial Intelligence Based on Medical Imaging in Glioma: Current State and Future Challenges.

Authors:  Jiaona Xu; Yuting Meng; Kefan Qiu; Win Topatana; Shijie Li; Chao Wei; Tianwen Chen; Mingyu Chen; Zhongxiang Ding; Guozhong Niu
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

5.  Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.

Authors:  Pengfei Guo; Mathias Unberath; Hye-Young Heo; Charles G Eberhart; Michael Lim; Jaishri O Blakeley; Shanshan Jiang
Journal:  Neuroimage Clin       Date:  2022-07-18       Impact factor: 4.891

Review 6.  Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.

Authors:  Abhishta Bhandari; Ravi Marwah; Justin Smith; Duy Nguyen; Asim Bhatti; Chee Peng Lim; Arian Lasocki
Journal:  J Med Imaging Radiat Oncol       Date:  2022-05-22       Impact factor: 1.667

Review 7.  Application of Artificial Intelligence in Diagnosis of Craniopharyngioma.

Authors:  Caijie Qin; Wenxing Hu; Xinsheng Wang; Xibo Ma
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

Review 8.  Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.

Authors:  Martin Kocher; Maximilian I Ruge; Norbert Galldiks; Philipp Lohmann
Journal:  Strahlenther Onkol       Date:  2020-05-11       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.